• Register
  • Login
  • Subscribe
  • Contact Us

Supply of Immunomodulator and Antineoplastic Drug

JordanTenders notice for Supply of Immunomodulator and Antineoplastic Drug. The reference ID of the tender is 67269026 and it is closing on 19 Jun 2022.

Tender Details

  • Country: Jordan
  • Summary: Supply of Immunomodulator and Antineoplastic Drug
  • JOT Ref No: 67269026
  • Deadline: 19 Jun 2022
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 2022000268-00
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • Tenders are invited for Supply of Immunomodulator and Antineoplastic Drug Tender 2022 DASATINIB TABS 50 MG JMOH: Provided a replacement undertaking KAUH: Provided a replacement pledge was made DASATINIB TABS 70 MG JUH: Pledge to replace IMATINIB TABS/CAP 100 MG JMOH: Provided a replacement pledge is provided IMATINIB TABS/CAP 400 MG JMOH: Provided a replacement pledge is provided LAPATINIB TABS 250 MG JMOH: Provided Substitution Undertaking DRMS: Replacement Undertaking Required JUH: Replacement Undertaking KAUH: Provided Substitution Undertaking NILOTINIB CAPS 150 MG NILOTINIB CAPS 200 MG SUNITINIB CAPS 12.5 MG SUNITINIB CAPS 25 MG SUNITINIB CAPS 50 MG RIBOCICLIB TAB 200 MG PALBOCICLIB CAP 75 MG PALBOCICLIB CAP 100 MG PALBOCICLIB CAP 125 MG Bid Copy Price 500 Jod How to Pay the Bid Fee on-Line/off-Line Deadline for Paying the Bid Fee 06/18/2022 23:59 Entry Guarantee 3% of the Value of the Entry Guarantee. The Entry Guarantee Must be Deposited in the Bidding Box before the Deadline for Submitting Bids How to Submit an Entry Guarantee on-Line/off-Line Entry Guarantee Validity 210 Days Entry Guarantee Expiry Date 01/15/2023 Start Date 06/01/2022 12:01 * Deadline for Submitting Bids 06/19/2022 10:59 Bid Opening Date 06/19/2022 11:00 [Disclaimer: The above text is machine translated. For accurate information kindly refer the original document.]
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Supply of Immunomodulator and Antineoplastic Drug - Jordan Tender

The GOVERNMENT PROCUREMENT DEPARTMENT, a Government sector organization in Jordan, has announced a new tender for Supply of Immunomodulator and Antineoplastic Drug. This tender is published on JordanTenders under JOT Ref No: 67269026 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-06-19.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

JordanTenders Features

JordanTenders Features

Fresh and verified Tenders from Jordan. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting JordanTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Jordan in your email inbox.

  Chat with us